DMK PHARMACEUTICALS CORPORATION: cashflow_financing
| Value | {"amount": 2114480, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"} |
|---|---|
| Period | 2011-04-01 – 2012-03-31 |
| Status | current |
| Entity | DMK PHARMACEUTICALS CORPORATION |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T08:54:22.688453+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/9a686aa5-e4f0-4d02-9130-f78994dba8d5
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001387131-12-002016 · Open the official SEC filing →Retrieved: 2026-08-19T08:54:22.688453+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000887247/cashflow-financing/2012-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/9a686aa5-e4f0-4d02-9130-f78994dba8d5
History
- no predecessors — first report